Potential new approach to treatment of chronic lung diseases

March 26, 2012

(Medical Xpress) -- Scientists at UCD have identified a potential new treatment for life-threatening complications associated with chronic obstructive lung diseases like emphysema and chronic bronchitis. Chronic obstructive lung diseases, most commonly caused by smoking, affect over 100,000 people in Ireland.

According to findings published recently in Circulation, it may be possible to target and regulate a protein that contributes to pulmonary - in the of the lung – a disabling and potentially fatal complication for patients suffering from chronic obstructive lung disease.

Conway Fellow, Professor Paul McLoughlin from UCD School of Medicine, who led the project said, “diseases such as , chronic and fibrosis of the lungs cause abnormally low levels of oxygen in the lung. When the lung is starved of oxygen, blood pressure in the arteries of the lung increases causing damage to blood vessels and making it more difficult for the heart to pump blood, leading in many cases to heart failure and premature death”.

While investigating the factors that contribute to high blood pressure in the arteries, the UCD research groups found that when oxygen levels in the lung are reduced, the body produces elevated quantities of a protein called gremlin – suggesting a link between elevated levels of gremlin and pulmonary hypertension.

Further investigations showed that mice whose genes had been mutated to reduce gremlin were protected against pulmonary hypertension, even when in a low oxygen environment similar to that found in lung disease. The heart was also protected and the damage to blood vessels in the lung was less severe.

Further research showed that gremlin was elevated in the lungs of patients with , confirming a key role for the protein in damaging the blood vessels of the lung.

“These research findings suggest the potential for additional novel treatments of patients by designing drugs that block the actions of gremlin in the lung”, said Professor McLoughlin.

More information: Cahill et al. Gremlin Plays a Key Role in the Pathogenesis of Pulmonary Hypertension. Circulation (2012) doi: 10.1161/​CIRCULATIONAHA.111.038125

Related Stories

Reversing smoke-induced damage and disease in the lung

October 13, 2011

By studying mice exposed to tobacco smoke for a period of months, researchers have new insight into how emphysema and chronic obstructive pulmonary disease (COPD) develops. In the October 14th issue of Cell they also report ...

Recommended for you

Experimental MERS vaccine shows promise in animal studies

July 28, 2015

A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines. ...

Can social isolation fuel epidemics?

July 21, 2015

Conventional wisdom has it that the more people stay within their own social groups and avoid others, the less likely it is small disease outbreaks turn into full-blown epidemics. But the conventional wisdom is wrong, according ...

Lack of knowledge on animal disease leaves humans at risk

July 20, 2015

Researchers from the University of Sydney have painted the most detailed picture to date of major infectious diseases shared between wildlife and livestock, and found a huge gap in knowledge about diseases which could spread ...

IBD genetically similar in Europeans and non-Europeans

July 20, 2015

The first genetic study of inflammatory bowel disease (IBD) to include individuals from diverse populations has shown that the regions of the genome underlying the disease are consistent around the world. This study, conducted ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.